TOMI Environmental Solutions makes and sells disinfection and decontamination systems under the SteraMist brand. The core technology, called Binary Ionization Technology (BIT), converts a low-concentration hydrogen peroxide solution into ionized hydrogen peroxide — a fog of submicron hydroxyl radical particles — through a cold plasma arc, achieving a 6-log (99.9999%) kill rate against a broad spectrum of pathogens. Customers use SteraMist to disinfect indoor environments and surfaces across pharmaceutical cleanrooms, hospital operating rooms, food processing facilities, biosafety labs, and commercial spaces. TOMI operates a razor/razor-blade model: equipment is sold once, while the BIT Solution consumable generates recurring, high-margin revenue over the life of the equipment. TOMI organizes around four divisions — Life Sciences, Hospital-Healthcare, Food Safety, and Commercial — with Life Sciences being the largest and most strategic. Products range from portable handheld units to permanently integrated custom systems for regulated pharmaceutical environments. TOMI sells through a direct sales force, independent reps, a global distributor network spanning roughly 40 countries, and a franchise-style certified service provider program. The company outsources all manufacturing to third-party contract manufacturers and operates with approximately 20 full-time employees. Growth priorities include scaling OEM partnerships that embed SteraMist into third-party enclosures, expanding the Food Safety division following a recent FDA ruling broadening hydrogen peroxide's permitted use as a food additive, and capitalizing on pharmaceutical manufacturing returning to the U.S.